Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for OPK

Stock NameOpko Health Inc
TickerOPK(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS68375N1037
LEI529900A4S2D4OGOJLL02

Show aggregate OPK holdings

News associated with OPK

OPKO Health (NASDAQ:OPK) versus Integer (NYSE:ITGR) Critical Review
OPKO Health (NASDAQ:OPK – Get Free Report) and Integer (NYSE:ITGR – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation and dividends. Insider and Institutional Ownership 64.6% of OPKO Health shares […] - 2025-09-16 04:26:59
OPKO Health, Inc. (NASDAQ:OPK) Receives $2.75 Average PT from Brokerages
OPKO Health, Inc. (NASDAQ:OPK – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the six analysts that are covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the […] - 2025-09-01 02:43:07
Tuesday 8/12 Insider Buying Report: LINE, OPK
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. On Friday, Lineage's CO-EXECUTIVE CHAIRMAN, Kevin Patrick Marchetti, made a $995,21 - 2025-08-12 14:33:46
OPKO Health, Inc. (NASDAQ:OPK) Stake Increased by XTX Topco Ltd
XTX Topco Ltd grew its holdings in OPKO Health, Inc. (NASDAQ:OPK – Free Report) by 58.8% in the first quarter, Holdings Channel.com reports. The firm owned 309,290 shares of the biotechnology company’s stock after purchasing an additional 114,486 shares during the period. XTX Topco Ltd’s holdings in OPKO Health were worth $513,000 as of its […] - 2025-08-07 05:38:49
OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Recommendation of “Buy” by Brokerages
Shares of OPKO Health, Inc. (NASDAQ:OPK – Get Free Report) have earned a consensus recommendation of “Buy” from the five analysts that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, three have assigned a buy recommendation and one has issued a strong buy recommendation […] - 2025-07-15 03:34:49
OPKO Health, Inc. (NASDAQ:OPK) Shares Purchased by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC increased its stake in shares of OPKO Health, Inc. (NASDAQ:OPK – Free Report) by 158.4% during the 1st quarter, Holdings Channel.com reports. The fund owned 74,706 shares of the biotechnology company’s stock after purchasing an additional 45,798 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in OPKO Health […] - 2025-07-11 04:48:01
Validea Kenneth Fisher Strategy Daily Upgrade Report - 6/18/2025
The following are today's upgrades for Validea's Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow and consistent profit margins.OMNICELL INC (OMCL) - 2025-06-18 06:30:33
OPKO Health, Inc. (NASDAQ:OPK) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of OPKO Health, Inc. (NASDAQ:OPK – Free Report) by 24.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 753,380 shares of the biotechnology company’s […] - 2025-06-10 04:28:48
Two Sigma Advisers LP Purchases 8,396 Shares of OPKO Health, Inc. (NASDAQ:OPK)
Two Sigma Advisers LP raised its stake in shares of OPKO Health, Inc. (NASDAQ:OPK – Free Report) by 2.3% in the fourth quarter, Holdings Channel reports. The fund owned 381,197 shares of the biotechnology company’s stock after acquiring an additional 8,396 shares during the period. Two Sigma Advisers LP’s holdings in OPKO Health were worth […] - 2025-06-04 04:48:50
OPKO Health, Inc. (NASDAQ:OPK) Shares Purchased by Two Sigma Investments LP
Two Sigma Investments LP raised its position in OPKO Health, Inc. (NASDAQ:OPK – Free Report) by 136.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,647,567 shares of the biotechnology company’s stock after buying an additional 949,671 shares during the […] - 2025-06-01 06:04:59
Validea Kenneth Fisher Strategy Daily Upgrade Report - 5/29/2025
The following are today's upgrades for Validea's Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow and consistent profit margins.OPKO HEALTH INC (OPK - 2025-05-29 05:48:03
OPKO Health, Inc. (NASDAQ:OPK) Shares Bought by Millennium Management LLC
Millennium Management LLC grew its position in shares of OPKO Health, Inc. (NASDAQ:OPK – Free Report) by 85.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,588,526 shares of the biotechnology company’s stock after acquiring an additional 2,112,382 shares during the quarter. […] - 2025-05-27 04:54:52
Financial Comparison: OPKO Health (NASDAQ:OPK) and Forte Biosciences (NASDAQ:FBRX)
Forte Biosciences (NASDAQ:FBRX – Get Free Report) and OPKO Health (NASDAQ:OPK – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings and analyst recommendations. Risk & Volatility Forte Biosciences has a […] - 2025-05-15 02:52:51
MetLife Investment Management LLC Buys 58,589 Shares of OPKO Health, Inc. (NASDAQ:OPK)
MetLife Investment Management LLC grew its position in OPKO Health, Inc. (NASDAQ:OPK – Free Report) by 40.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 202,165 shares of the biotechnology company’s stock after purchasing an additional 58,589 shares during the quarter. […] - 2025-05-08 05:04:48
Renaissance Technologies LLC Sells 312,950 Shares of OPKO Health, Inc. (NASDAQ:OPK)
Renaissance Technologies LLC decreased its stake in shares of OPKO Health, Inc. (NASDAQ:OPK – Free Report) by 68.2% during the 4th quarter, HoldingsChannel.com reports. The firm owned 145,977 shares of the biotechnology company’s stock after selling 312,950 shares during the quarter. Renaissance Technologies LLC’s holdings in OPKO Health were worth $215,000 as of its most […] - 2025-05-07 04:27:10
Wells Fargo & Company MN Has $337,000 Stock Position in OPKO Health, Inc. (NASDAQ:OPK)
Wells Fargo & Company MN raised its holdings in OPKO Health, Inc. (NASDAQ:OPK – Free Report) by 14.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 229,262 shares of the biotechnology company’s stock after purchasing an additional 29,738 shares during the quarter. […] - 2025-05-06 04:52:55
OPKO Health, Inc. (NASDAQ:OPK) Shares Sold by Legal & General Group Plc
Legal & General Group Plc cut its holdings in shares of OPKO Health, Inc. (NASDAQ:OPK – Free Report) by 16.9% during the fourth quarter, Holdings Channel reports. The firm owned 370,438 shares of the biotechnology company’s stock after selling 75,178 shares during the quarter. Legal & General Group Plc’s holdings in OPKO Health were worth […] - 2025-04-29 05:34:48
ExodusPoint Capital Management LP Acquires Shares of 173,700 OPKO Health, Inc. (NASDAQ:OPK)
ExodusPoint Capital Management LP acquired a new stake in shares of OPKO Health, Inc. (NASDAQ:OPK – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 173,700 shares of the biotechnology company’s stock, valued at approximately $255,000. Other institutional investors have […] - 2025-04-14 04:46:53
OPKO Health (NASDAQ:OPK) Sees Strong Trading Volume on Insider Buying Activity
OPKO Health, Inc. (NASDAQ:OPK – Get Free Report) shares saw an uptick in trading volume on Wednesday following insider buying activity. 3,744,040 shares were traded during trading, a decline of 8% from the previous session’s volume of 4,068,860 shares.The stock last traded at $1.67 and had previously closed at $1.66. Specifically, CEO Phillip Md Et […] - 2025-04-04 02:17:06
Phillip Md Et Al Frost Acquires 150,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock
OPKO Health, Inc. (NASDAQ:OPK – Get Free Report) CEO Phillip Md Et Al Frost acquired 150,000 shares of the firm’s stock in a transaction dated Friday, March 28th. The shares were acquired at an average price of $1.70 per share, for a total transaction of $255,000.00. Following the acquisition, the chief executive officer now directly […] - 2025-03-31 05:07:00
Charles Schwab Investment Management Inc. Cuts Position in OPKO Health, Inc. (NASDAQ:OPK)
Charles Schwab Investment Management Inc. lowered its stake in shares of OPKO Health, Inc. (NASDAQ:OPK – Free Report) by 17.0% during the fourth quarter, Holdings Channel reports. The institutional investor owned 3,497,406 shares of the biotechnology company’s stock after selling 714,949 shares during the period. Charles Schwab Investment Management Inc.’s holdings in OPKO Health were […] - 2025-03-26 05:52:55
OPKO Health (NASDAQ:OPK) Receives “Buy” Rating from HC Wainwright
HC Wainwright reiterated their buy rating on shares of OPKO Health (NASDAQ:OPK – Free Report) in a research report sent to investors on Wednesday morning,Benzinga reports. The brokerage currently has a $3.00 target price on the biotechnology company’s stock. HC Wainwright also issued estimates for OPKO Health’s Q2 2025 earnings at ($0.07) EPS and FY2025 […] - 2025-03-20 05:44:57
OPKO Health (NASDAQ:OPK) Given Outperform Rating at Barrington Research
OPKO Health (NASDAQ:OPK – Get Free Report)‘s stock had its “outperform” rating reissued by equities researchers at Barrington Research in a report released on Wednesday,Benzinga reports. They currently have a $2.25 price objective on the biotechnology company’s stock. Barrington Research’s price objective would indicate a potential upside of 30.81% from the stock’s previous close. Several […] - 2025-03-14 05:15:06
OPKO Health (NASDAQ:OPK) Raised to Hold at StockNews.com
StockNews.com upgraded shares of OPKO Health (NASDAQ:OPK – Free Report) from a sell rating to a hold rating in a research report sent to investors on Monday. Several other equities analysts also recently weighed in on the stock. Barrington Research reaffirmed an “outperform” rating and set a $2.25 price target on shares of OPKO Health […] - 2025-03-04 06:22:47
Stock Traders Buy Large Volume of Call Options on OPKO Health (NASDAQ:OPK)
OPKO Health, Inc. (NASDAQ:OPK – Get Free Report) saw some unusual options trading on Monday. Stock investors acquired 9,645 call options on the stock. This represents an increase of 402% compared to the typical volume of 1,921 call options. OPKO Health Stock Down 4.7 % Shares of NASDAQ OPK opened at $1.64 on Wednesday. The […] - 2025-02-26 04:20:55
Exchange Traded Concepts LLC Has $517,000 Holdings in OPKO Health, Inc. (NASDAQ:OPK)
Exchange Traded Concepts LLC decreased its position in OPKO Health, Inc. (NASDAQ:OPK – Free Report) by 9.1% during the 4th quarter, HoldingsChannel reports. The fund owned 351,896 shares of the biotechnology company’s stock after selling 35,212 shares during the quarter. Exchange Traded Concepts LLC’s holdings in OPKO Health were worth $517,000 as of its most […] - 2025-01-31 06:35:05

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc OPK holdings

DateNumber of OPK Shares HeldBase Market Value of OPK SharesLocal Market Value of OPK SharesChange in OPK Shares HeldChange in OPK Base ValueCurrent Price per OPK Share HeldPrevious Price per OPK Share Held
2025-09-26 (Friday)94,073USD 136,406USD 136,406
2025-09-25 (Thursday)94,073USD 134,524OPK holding decreased by -4704USD 134,5240USD -4,704 USD 1.43 USD 1.48
2025-09-24 (Wednesday)94,073USD 139,228USD 139,228
2025-09-17 (Wednesday)93,463USD 129,914USD 129,9140USD 0 USD 1.39 USD 1.39
2025-09-16 (Tuesday)93,463USD 129,914USD 129,914
2025-09-12 (Friday)92,853USD 129,994USD 129,994
2025-09-11 (Thursday)92,853USD 132,780USD 132,780
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of OPK by Blackrock for IE00B3VWM098

Show aggregate share trades of OPK

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-08-21SELL-305 1.380* 1.49 Profit of 455 on sale
2025-07-31BUY912 1.280* 1.50
2025-06-30SELL-608 1.320* 1.51 Profit of 920 on sale
2025-06-25SELL-304 1.270* 1.52 Profit of 461 on sale
2025-06-20SELL-610 1.290* 1.52 Profit of 928 on sale
2025-05-23BUY305 1.260* 1.55
2025-05-19SELL-305 1.330* 1.56 Profit of 476 on sale
2025-05-15SELL-915 1.330* 1.57 Profit of 1,432 on sale
2025-05-12SELL-305 1.260* 1.57 Profit of 480 on sale
2025-05-09SELL-305 1.240* 1.58 Profit of 481 on sale
2025-04-30SELL-305 1.380* 1.59 Profit of 486 on sale
2025-04-24SELL-610 1.460* 1.60 Profit of 976 on sale
2025-04-17SELL-305 1.420* 1.61 Profit of 491 on sale
2025-04-15SELL-915 1.440* 1.61 Profit of 1,476 on sale
2025-04-14SELL-915 1.420* 1.62 Profit of 1,478 on sale
2025-04-09SELL-1,220 1.490* 1.62 Profit of 1,979 on sale
2025-04-07SELL-2,135 1.530* 1.62 Profit of 3,469 on sale
2025-04-04SELL-3,050 1.550* 1.63 Profit of 4,958 on sale
2025-03-31BUY305 1.660* 1.62
2025-03-19SELL-610 1.860* 1.61 Profit of 980 on sale
2025-03-14SELL-1,836 1.740* 1.60 Profit of 2,938 on sale
2025-03-13SELL-612 1.720* 1.60 Profit of 978 on sale
2025-03-12SELL-10,404 1.780* 1.60 Profit of 16,602 on sale
2025-03-07SELL-612 1.900* 1.58 Profit of 970 on sale
2025-03-06SELL-921 1.890* 1.58 Profit of 1,455 on sale
2025-03-03SELL-307 1.750* 1.57 Profit of 481 on sale
2025-02-28SELL-1,842 1.740* 1.56 Profit of 2,879 on sale
2025-02-26SELL-307 1.660* 1.56 Profit of 479 on sale
2025-02-25SELL-921 1.640* 1.56 Profit of 1,436 on sale
2025-02-18BUY1,535 1.720* 1.54
2025-02-13BUY307 1.660* 1.54
2025-02-12BUY307 1.640* 1.53
2025-02-11BUY921 1.620* 1.53
2025-02-06BUY2,754 1.620* 1.53
2025-01-27BUY306 1.470* 1.53
2024-12-30BUY1,530 1.470* 1.53
2024-12-06BUY1,224 1.590* 1.53
2024-12-05BUY306 1.570* 1.53
2024-12-04BUY1,530 1.560* 1.53
2024-11-29BUY1,530 1.540* 1.53
2024-11-27BUY1,224 1.580* 1.52
2024-11-26BUY306 1.550* 1.52
2024-11-21BUY1,528 1.560* 1.51
2024-11-20BUY915 1.580* 1.50
2024-11-18BUY3,660 1.640* 1.49
2024-11-12BUY2,440 1.610* 1.48
2024-11-08BUY1,525 1.520* 1.48
2024-11-07BUY4,560 1.450* 1.48
2024-11-06BUY608 1.470* 1.48
2024-10-31BUY304 1.510* 1.48
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of OPK

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19840,77421,486,34256.6%
2025-09-18839,21301,702,89849.3%
2025-09-17460,3341,500918,51050.1%
2025-09-16354,6200828,80442.8%
2025-09-15350,78711,998866,66240.5%
2025-09-12277,81424544,59851.0%
2025-09-11304,4990836,14336.4%
2025-09-10249,8860721,43534.6%
2025-09-09303,61501,721,56917.6%
2025-09-08881,70101,188,20474.2%
2025-09-05370,1131,995662,30355.9%
2025-09-04294,0860632,74746.5%
2025-09-03395,154835818,83748.3%
2025-09-02529,4601,056882,05460.0%
2025-08-29323,6951,711622,47452.0%
2025-08-28382,4091,501667,05257.3%
2025-08-27342,7081,500617,57955.5%
2025-08-26406,5701,700632,92664.2%
2025-08-25337,7166,192923,06736.6%
2025-08-22483,11701,321,00236.6%
2025-08-21361,8081,510659,81554.8%
2025-08-20396,6853699,15356.7%
2025-08-19282,9670628,20045.0%
2025-08-18528,0882,7521,152,40245.8%
2025-08-15275,7300550,54850.1%
2025-08-14287,0944,461502,63657.1%
2025-08-13459,3753,867952,20848.2%
2025-08-12610,6383,0991,171,59052.1%
2025-08-11733,21201,579,93546.4%
2025-08-08734,14410,3481,478,69449.6%
2025-08-07764,5407,0011,457,97752.4%
2025-08-06618,6206001,182,11252.3%
2025-08-05921,94322,0261,428,25164.6%
2025-08-04946,923177,6511,862,08050.9%
2025-08-012,401,770265,5264,385,93454.8%
2025-07-31940,22096,8381,863,84050.4%
2025-07-30432,1452,228991,05543.6%
2025-07-29337,89301,010,67333.4%
2025-07-28223,557921586,09138.1%
2025-07-25341,3020909,15937.5%
2025-07-24359,2250719,08550.0%
2025-07-23952,8657741,890,27250.4%
2025-07-22637,4534001,940,11232.9%
2025-07-21950,49402,635,37536.1%
2025-07-18433,5880941,13846.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.